Mixed
Surgical weight loss via Roux-en-Y gastric bypass (RYGB) induces a distinct gut microbiome shift characterized by a 52-fold increase in phylum Proteobacteria and a decrease in the Firmicutes-to-Bacteroidetes ratio, which correlates with improved insulin sensitivity and weight loss.
If you undergo Roux-en-Y gastric bypass, your gut bacteria will change significantly, specifically an increase in Proteobacteria. This shift is unique to surgery and not seen in non-surgical weight loss. While causality is still being studied, this microbial change is associated with improved insulin sensitivity and weight loss. Consult a bariatric surgeon to understand if this anatomical change is appropriate for your metabolic health.
One major finding from microbial sequencing analyses after Roux-en-Y gastric bypass is the comparative overabundance of Proteobacteria in the distal gut microbiome, which is distinct from the changes seen in weight loss without Roux-en-Y gastric bypass.
Why this rating
Based on a review of multiple studies (including human and rodent models) showing consistent trends, though causality is noted as difficult to establish.
Source
The Human Gut Microbiome
Timothy E. Sweeney et al. · JAMA Surgery · 2013
DOI 10.1001/jamasurg.2013.5
More from this paper
- Supplementation with Lactobacillus probiotics after Roux-en-Y gastric bypass increases weight loss and reduces bacterial overgrowth compared to placebo.Good
- Obesity is associated with an elevated Firmicutes-to-Bacteroidetes ratio in the gut, which decreases following weight loss, although some studies show conflicting results.Moderate
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →